Science Friday

The Science Of Replacing Body Parts, From Hair To Hearts

In “Replaceable You,” Mary Roach describes mind-boggling efforts to replace human body parts—and why it’s proven to be so ...

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients …

Positive results from the TROPION-Breast02 phase 3 trial showed DATROWAY® (datopotamab deruxtecan) demonstrated a ...

IMFINZI® (durvalumab) regimen reduced the risk of disease recurrence or death by 32% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Barron's

Cadence Design Systems Inc.

About Cadence Design Systems Inc. Cadence Design Systems, Inc. engages in the provision of design and development of integrated circuits and electronic devices. It operates through the following ...
Forbes

Obesity Statistics and Facts In 2025

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...